Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
PFE: Department of Defense contract award
4572451648!PROTONIX IV 40 MG VIALS
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572451649!METOPROLOL TART 5 MG/5 ML VIAL 5ML
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572451647!LIDOCAINE HCL 1% VIAL 50ML
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572454271!CEFTRIAXONE 1 GM VIALS
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572463593!PROTONIX IV 40 MG VIALS
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572464429!SILVADENE 1% CREAM 20GM
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572464431!PROVERA 10 MG TABLET 100S
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572465630!FENTANYL 100 MCG/2 ML VIAL 2ML
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4572465632!SILVADENE 1% CREAM 20GM
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4569621025!CYKLOKAPRON 1,000 MG/10 ML VL 10ML
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
4570449896!SOLU-MEDROL 125 MG VIALS
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Health and Human Services contract award
PFIZER VACCINES STORAGE AND ROTATION CONTRACT
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Department of Defense contract award
COVID-19 VACCINE PRODUCTION
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Leadership change
Filed 8-K for an event or period dated 2026-10-30. Leadership change.
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
PFE: Financial results
Filed 8-K for an event or period dated 2026-11-03. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
Jeffrey Thies: Final Debarment Order
The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jeffrey Thies for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Thies was convicted of two felony counts under Federal law for trafficking in counterfeit goods and aiding and abetting. The factual basis supporting Mr. Thies's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Thies was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of July 13, 2026 (more than 30 days after receipt of the notice), Mr. Thies had not responded. Mr. Thies's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.
Public: Sep 25, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Advisory Committee; Oncologic Drugs Advisory Committee; Renewal
The Food and Drug Administration (FDA) is announcing the renewal of the Oncologic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Oncologic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the September 1, 2028, expiration date.
Public: Aug 21, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Foreign-Trade Zone (FTZ) 43, Notification of Proposed Production Activity; Pfizer Inc.; (Pharmaceutical Products); Kalamazoo and Portage, Michigan
A Notice notice explicitly mentions the company. Read the cited text for its role.
Public: Jul 20, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Self-Regulatory Organizations; NYSE American LLC; Notice of Filing of a Proposed Rule Change To Amend Rule 903G and 906G
A Notice notice explicitly mentions the company. Read the cited text for its role.
Public: Jul 7, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing of a Proposed Rule Change To Amend Rules 5.32-O and 5.35-O
A Notice notice explicitly mentions the company. Read the cited text for its role.
Public: Jul 7, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 34 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Public: Jul 6, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Determination That Protamine Sulfate (Protamine Sulfate) Intravenous; Solution, 50 Milligrams/5 Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements.
Public: Jun 8, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Partial coverage — some requests unavailable455 of 455 companies scanned in the past 12 hoursLatest successful company scan: Nov 9, 2026, 1:16 AM EST
- USAspending
- Partial coverage — some requests unavailable290 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 9, 2026, 1:07 AM EST
- SAM.gov
- Not connected
- Lobbying disclosures
- Partial coverage — some requests unavailable76 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 9, 2026, 1:08 AM EST
- Congress.gov
- Current across tracked companies2 of 2 companies scanned in the past 12 hoursLatest successful company scan: Nov 8, 2026, 11:17 PM EST
- Federal Register
- Partial coverage — some requests unavailable411 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 9, 2026, 1:09 AM EST
- Regulations.gov
- Collection in progress24 of 51 companies scanned in the past 12 hoursLatest successful company scan: Nov 9, 2026, 12:48 AM EST
- FEC campaign finance
- Stale — refresh overdue264 of 495 companies scanned in the past 12 hoursLatest successful company scan: Nov 9, 2026, 1:09 AM EST